Ray Dalio Edwards Lifesciences Corp Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 62,522 shares of EW stock, worth $4.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

62,522

Previous 108,285 42.26%

Holding current value

$4.88 Million

Previous $8.02 Million 43.48%

% of portfolio

0.02%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$67.95 - $76.19 $3.11 Million - $3.49 Million	-45,763 Reduced 42.26%	62,522 $4.53 Million
Q4 2024 Feb 13, 2025	SELL	$64.54 - $75.92 $3.69 Million - $4.34 Million	-57,166 Reduced 34.55%	108,285 $8.02 Million
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $21.2 Million - $33.2 Million	-354,361 Reduced 68.17%	165,451 $10.9 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $2.88 Million - $3.22 Million	34,145 Added 7.03%	519,812 $48 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $30.3 Million - $39.9 Million	-417,561 Reduced 46.23%	485,667 $46.4 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $9.4 Million - $11.8 Million	-152,368 Reduced 14.43%	903,228 $68.9 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $18.9 Million - $25.5 Million	273,312 Added 34.94%	1,055,596 $73.1 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $13.1 Million - $15.2 Million	-160,942 Reduced 17.06%	782,284 $73.8 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $2.72 Million - $3.1 Million	36,667 Added 4.04%	943,226 $78 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $15.3 Million - $19.6 Million	-224,153 Reduced 19.82%	906,559 $67.6 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $11.1 Million - $14.5 Million	135,355 Added 13.6%	1,130,712 $93.4 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $12.1 Million - $17.9 Million	-139,899 Reduced 12.32%	995,357 $94.6 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $33.5 Million - $42.1 Million	328,371 Added 40.7%	1,135,256 $134 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $12.5 Million - $15.3 Million	117,220 Added 17.0%	806,885 $105 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $784,071 - $935,232	-7,619 Reduced 1.09%	689,665 $78.1 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $25.8 Million - $32.2 Million	307,385 Added 78.84%	697,284 $72.2 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $6.03 Million - $6.95 Million	76,657 Added 24.47%	389,899 $32.6 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $12.2 Million - $15.5 Million	169,585 Added 118.05%	313,242 $28.6 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $9.65 Million - $12.6 Million	143,657 New	143,657 $11.5 Million
Q2 2020 Aug 12, 2020	SELL	$57.54 - $76.95 $141,663 - $189,450	-2,462 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $129,033 - $199,422	2,462 New	2,462 $464,000
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $686,957 - $786,504	-9,581 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $130,116 - $159,459	2,114 Added 28.31%	9,581 $2.11 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $416,210 - $480,949	7,467 New	7,467 $1.38 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $445,071 - $546,054	-9,590 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $438,263 - $556,507	9,590 New	9,590 $1.67 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $1.22 Million - $1.56 Million	-32,832 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $2.94 Million - $3.42 Million	-86,915 Reduced 72.58%	32,832 $3.7 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $4.35 Million - $4.65 Million	119,747	119,747 $13.1 Million

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

487M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account